Masimo debuts 1st iPhone pulse oximeter

December 12, 2012 by MassDevice staff

Medical device company Masimo unveils the iSpO2, the 1st Apple-approved pulse oximetry system compatible with iPods, iPhones and iPads.

Masimo's iSpO2 system

Medical device maker Masimo (NSDQ:MASI) today unveiled its iSpO2, a novel pulse oximetry system for use with iPods, iPhones and iPads, the company's 1st consumer-marketed product.

Patients can use the iSpO2 device to measure blood oxygenation, pulse rate and a perfusion index using a finger sensor and a cable that connects to their mobile devices.

The Irvine, Calif.-based medical device company is the 1st to bring an iOS-friendly pulse oximetry system to the market, using technology from its existing line of pulse oximeters and CO-Oximeters used in clinical settings.

Sign up to get our free newsletters delivered right to your inbox.

The iSpO2 system is not yet cleared for medical use, but Masimo has a professional version of the system undergoing CE Mark review in the European Union as well as 510(k) clearance in the U.S., according to a statement sent to today.

"Masimo was founded on a mission to take noninvasive monitoring to new sites and applications," Masimo founder & CEO Joe Kiani said in prepared remarks. "The iSpO2 for iPhone, iPad or iPod touch with 30-pin connector represents our 1st consumer product and should create myriad new possibilities with the goal of further empowering people."